Suchergebnisse - "Deng, Liting"

PubPharm (7)

1

Prophylactic treatment with the tricyclic antidepressant desipramine prevents development of paclitaxel-induced neuropathic pain through activation of endogenous analgesic systems

enthalten in: Pharmacological research | 2016

von Deng, L. | Lee, W. | Xu, Z. | +2

2

CB1 Knockout Mice Unveil Sustained CB2-Mediated Antiallodynic Effects of the Mixed CB1/CB2 Agonist CP55,940 in a Mouse Model of Paclitaxel-Induced Neuropathic Pain

enthalten in: Molecular pharmacology | 2015

von Deng, L. | Cornett, B. | Mackie, K. | +1

3

Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal

enthalten in: Biological psychiatry | 2015

von Deng, L. | Guindon, J. | Cornett, B. | +3

4

Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery

enthalten in: Molecular pain | 2014

von Rahn, E. | Deng, L. | Thakur, G. | +5

5

Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery

enthalten in: Molecular pain | 2014

von Rahn, E. | Deng, L. | Thakur, G. | +5

6

Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery

enthalten in: Molecular pain | 2014

von Rahn, E. | Deng, L. | Thakur, G. | +5

7

The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CB₂ receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy

enthalten in: Molecular pain | 2012

von Deng, L. | Guindon, J. | Vemuri, V. | +4

1
[1]